Hibiscus Sabdariffa Extract Effect on Neuromuscular Performance
NCT ID: NCT05653076
Last Updated: 2023-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2023-01-23
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Effect of the Combined Extract of Lemon Verbena and Hibiscus on Health Indicators
NCT05906771
Effect of Hibiscus and Lippia Extract on Blood Pressure
NCT03507023
The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure
NCT00175110
Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products
NCT05988554
Helichrysum Italicum Infusion Ingestion in Humans
NCT04818905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Microcrystalline cellulose
Hibiscus sabdariffa extract
Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.
Hibiscus sabdariffa extract
520 mg of Hibiscus sabdariffa extract
Hibiscus sabdariffa extract
Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hibiscus sabdariffa extract
Daily supplementation with 520 mg of Hibiscus sabdariffa extract for 10 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index: 18.5-30 kg/m2
* Be able to understand the instructions, objectives, and protocol of the study.
* Trained in some force sports discipline ≥1 year prior to the study and accustomed to carrying out the exercises of the evaluation protocol.
Exclusion Criteria
* Any chronic pathology in which the intake of nutritional supplements is not recommended.
* Any condition that, in the investigator's judgment, impairs the ability to participate in the study or represents a personal risk to the participant.
* Use of medications that may affect the results of the study.
* Unstable body weight for 3 months prior to study start (\>4 kg weight gain or loss)
* Routine use of teas/infusions/supplements rich in polyphenols.
* Pregnancy and lactation.
* Active tobacco or illicit drug use or history of treatment for alcohol abuse.
* To be on a special diet or prescribed for other reasons (eg celiac disease).
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francisco Javier Osuna-Prieto
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Mixto Universitario Deporte y Salud (iMUDS)
Granada, , Spain
Facultad de Ciencias del Deporte
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1364-N-22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.